The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An open-label phase II study to evaluate PT2977 for the treatment of von Hippel-Lindau disease-associated renal cell carcinoma.
 
Eric Jonasch
Consulting or Advisory Role - Eisai; Exelixis; Genentech/Roche; Novartis; Pfizer
Research Funding - Exelixis; Novartis; Peloton Therapeutics; Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Eric Kristopher Park
Employment - Peloton Therapeutics
Stock and Other Ownership Interests - Peloton Therapeutics
 
Sanjay Thamake
Employment - Peloton Therapeutics
Stock and Other Ownership Interests - Peloton Therapeutics
Travel, Accommodations, Expenses - Peloton Therapeutics
 
Mohammad Hirmand
Employment - Peloton Therapeutics
Leadership - Peloton Therapeutics
Stock and Other Ownership Interests - Peloton Therapeutics
 
W. Marston Linehan
No Relationships to Disclose
 
Ramaprasad Srinivasan
Research Funding - AstraZeneca (Inst); Calithera Biosciences (Inst); Peloton Therapeutics (Inst); Sanofi (Inst)